Evidence map›Paper›PMID 42455947›Full record

ArticleScience advances2026

Transcription initiation drives dosage compensation establishment and maintenance in male

Ronald Oellers, Anastasios Alexiadis, Yidan Sun, Mohit Navandar, Tanvi Kulkarni, Herbert Holz, Plamen Georgiev, Leily Rabbani, Maria Shvedunova, Niyazi Umut Erdogdu and 4 more

Abstract read
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ronald OellersMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.ORCID 0000-0002-1650-8226
Anastasios AlexiadisMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.ORCID 0009-0000-6264-0714
Yidan SunMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.ORCID 0000-0003-4019-8077
Mohit NavandarMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.ORCID 0009-0009-7377-6153
Tanvi KulkarniMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.ORCID 0000-0003-1996-7097
Herbert HolzMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.ORCID 0009-0008-0017-5384
Plamen GeorgievMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Leily RabbaniMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.ORCID 0009-0007-0755-3643
Maria ShvedunovaMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.ORCID 0000-0003-3761-4535
Niyazi Umut ErdogduMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.ORCID 0000-0001-7383-8953
Patrick CramerMax Planck Institute for Multidisciplinary Sciences, Goettingen, Germany.
Michael LidschreiberMax Planck Institute for Multidisciplinary Sciences, Goettingen, Germany.ORCID 0000-0002-6740-2755
Asifa AkhtarMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.ORCID 0000-0001-8973-6193

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dosage compensation (DC) in

Indexed as

Dosage Compensation, GeneticDrosophilaDrosophila melanogasterTranscription, GeneticAnimalsDrosophila ProteinsGene Expression Regulation, DevelopmentalMaleRNA Polymerase IIX ChromosomeDrosophila ProteinsRNA Polymerase II

Identifiers

PMID42455947
PMCPMC13371929

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.